New plasma biomarker to detect Alzheimer’s disease in Down syndrome individuals
Plasma biomarkers Scientists worldwide are immersed in the race for accurate, non-invasive and accessible biomarkers to detect and diagnose Alzheimer’s Disease. To date, major scientific advances allowed the identification of several biomarkers in cerebrospinal fluid...
Dr. Oriol Dols-Icardo, awarded by Fundación hna
Research award by Fundación hna Fundación hna has awarded Dr. Oriol Dols-Icardo the prize of the first edition of the “Premio de Investigación Científica de Salud“. This is a competitive call for funding a research project on Amyotrophic Lateral Sclerosis...
Blood biomarkers are useful to detect Alzheimer’s disease
Blood biomarkers for Alzheimer’s disease Recent developments in blood markers have made possible to track the different pathophysiological processes that occur in Alzheimer’s disease through plasma analysis. Our study “Use of plasma biomarkers for AT...
What is the value of brain atrophy in frontotemporal dementia?
Atrophy and frontotemporal dementia The behavioral variant of frontotemporal dementia is a frequent cause of neurodegenerative dementia and the first cause of Frontotemporal Lobular Degeneration. Patients with the behavioral variant of frontotemporal dementia present...
Marta Querol defends her doctoral thesis
Marta Querol Vilaseca has presented her doctoral thesis entitled “New methods of digital neuropathology applied to neurodegenerative diseases“. The thesis has been directed and tutored by Dr. Alberto Lleó, and discusses new methodologies that are useful to...
Structural changes in the brain of patients with Alzheimer’s begin 20 years before the symptoms onset
Structural brain changes in Alzheimer’s disease Brain alterations in Alzheimer’s disease patients begin years before symptoms appear and a clinical diagnosis can be made. The neuroimaging team in our group has developed a technique that measures the...
Neurofilament and total tau in plasma for the diagnosis of frontotemporal dementia and Alzheimer’s
The Sant Pau Memory Unit publishes a new study in collaboration with the University of California San Francisco. The study examines the role of neurofilament light chain (NfL) and total tau levels in plasma for the diagnosis of frontotemporal dementia and...
Overlapping microstructural changes in the brain of patients with ALS and frontotemporal dementia
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) Until a few years ago, amyotrophic lateral sclerosis or ALS was considered a neurodegenerative disease that caused a progressive loss of strength with preservation of intellectual functions....